菜創利 Presents to FDA on Oversight Considerations for GenAI Medical Devices
The 菜創利速 presented at the U.S. FDA Digital Health Advisory Committee meeting Total Product Lifecycle Considerations for Generative AI-Enabled Devices. Bernardo Bizzo, MD, PhD, 菜創利 Data Science Institute速 Associate Chief Science Officer, represented the College at the meeting.
Read more